1. Structural studies of Class I MHC antigens. The structural analysis of naturally occurring population variants of Class I HLA antigens HLA-A2, -B7, -B27 and -B8, will be carried out in order to define functional sites in these molecules. 2. Structural studies of Class II MHC antigens. The separation of subsets of Class II HLA antigens (HLA-Dr, DQ and DP) at the protein level is essential for full characterization and, in particular, to investigate several novel features of the SQ and DP subsets, as well as to obtain materials for use in crystallization and in functional studies. The structures of the DQ2 Alpha and Beta alleles in normal individuals and in patients with coeliac disease will be investigated in order to establish whether or not the linkage of this autoimmune disease to DQ1 is associated with a particular 'disease allele'. The structures of two DRw6Beta chains in two DRw6 cells (WT46 and WT52) will be examined to ascertain if genetic exchange between DRBeta alleles may have led to the generation of these cell lines. 3. The interaction of Class I and Class II MHC antigens with human T cell specific proteins T4 and T8. Several techniques will be employed to examine the possibility that a functionally important protein-protein interaction can occur between these molecules. 4. The crystal structures of immunologically important molecules. The crystal structure of HLA-A2 is advancing rapidly and will be completed. Crystallization of a secreted form of HLA-A2 will also be attempted. Attempts to obtain, crystallize and examine the crystal structure of a soluble form of HLA-DR1 and of both water soluble and detergent soluble forms of the T cell specific protein T8 will be made. Finally, the use of genetic manipulation to obtain soluble forms of immunologically important molecules for crystallographic studies will be explored.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI010736-14
Application #
3124806
Study Section
Immunobiology Study Section (IMB)
Project Start
1976-02-01
Project End
1989-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
14
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Arts and Sciences
DUNS #
071723621
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Pioli, P A; Rigby, W F (2001) The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. J Biol Chem 276:40346-52
Groh, V; Porcelli, S; Fabbi, M et al. (1989) Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 169:1277-94
Gorga, J C; Dong, A; Manning, M C et al. (1989) Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy. Proc Natl Acad Sci U S A 86:2321-5
Sleckman, B P; Peterson, A; Foran, J A et al. (1988) Functional analysis of a cytoplasmic domain-deleted mutant of the CD4 molecule. J Immunol 141:49-54
Domenech, N; Ezquerra, A; Castano, R et al. (1988) Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes. Immunogenetics 27:196-202
Castano, R; Ezquerra, A; Domenech, N et al. (1988) An HLA-A2 population variant with structural polymorphism in the alpha 3 region. Immunogenetics 27:345-55
Kappes, D; Strominger, J L (1988) Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem 57:991-1028
Gorga, J C; Horejsi, V; Johnson, D R et al. (1987) Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem 262:16087-94
Tanigaki, N; Tosi, R; Strominger, J L et al. (1987) Immunochemistry of the HLA class II molecules isolated from a mouse cell transfected with DQ alpha and beta genes from a DR4 haplotype. Immunogenetics 26:40-7
Strominger, J L (1987) Structure of class I and class II HLA antigens. Br Med Bull 43:81-93

Showing the most recent 10 out of 33 publications